Biological Diagnostic Nomenclature (BDN): A Mechanism-Based Framework for Replacing Symptom-Based Psychiatric Diagnosis
Contemporary psychiatric diagnosis remains predominantly based on descriptive phe-nomenology rather than objectively measurable biological mechanisms. Although thissymptom-based approach has improved diagnostic reliability, it has shown limited valid-ity with respect to etiology, prognosis, biomarker development, and precision treatment.Advances in neuroscience over the past three decades have identified reproducible alterationsin neurotransmitter systems, neural circuits, genetics, neuroimaging, electrophysiology, im-mune signaling, and chronobiology across major psychiatric disorders. These findings suggestthat many traditional diagnostic categories represent heterogeneous clinical syndromes arisingfrom partially identifiable neurobiological dysregulation rather than discrete disease entities.This article proposes Biological Diagnostic Nomenclature (BDN), a mechanism-oriented nosological framework intended to complement and eventually replace purelysymptom-based psychiatric terminology. Rather than naming disorders according to observedbehaviors or historical constructs, BDN assigns diagnostic labels according to the predomi-nant biological systems whose dysregulation best explains the underlying pathophysiology.Within this framework, disorders are conceptualized as dynamic neurobiological states thatcan be further stratified by molecular biomarkers, circuit dysfunction, genetic susceptibility,inflammatory signatures, and disease trajectory.BDN is designed as an extensible classification system in which individual diagnosticentities are progressively incorporated as sufficient biological evidence accumulates. Initial ex-amples include Dopaminergic–Glutamatergic Dysregulation Disorder (DGDD), Dopaminergic–Serotoninergic–Noradrenergic Dysregulation Disorder (DSNDD), Serotoninergic DysregulationDisorder (SDD), and Serotoninergic–Dopaminergic–Glutamatergic–GABAergic Dysregula-tion Disorder (SDGGDD), each representing biologically informed reformulations of existingpsychiatric syndromes. Future editions may incorporate additional mechanism-based entitiesas validated biomarkers become available.Rather than proposing an immediate replacement for current diagnostic systems, BDNshould be regarded as a translational research framework that aligns psychiatric nomenclaturewith contemporary neuroscience, biomarker discovery, and precision medicine. By shiftingemphasis from descriptive phenomenology to biological mechanisms, Biological DiagnosticNomenclature aims to facilitate more accurate diagnosis, individualized treatment selection,improved prognosis, and reduced diagnostic stigma while providing a scalable foundation forfuture biologically grounded psychiatric classification.1Biological Diagnostic Nomenclature; psychiatric classification; precision psychiatry; biomark-ers; transdiagnostic psychiatry; neurobiology; systems neuroscience; mechanism-based diagnosis;precision medicine; nosology
Authors
- Martín Fuertes Oliva (ORCID: https://orcid.org/0009-0002-5683-1383)
Institutions
- Universidad Nacional de Educación a Distancia (ES)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5281/zenodo.24201330
- Primary Topic
- Mental Health and Psychiatry
- Type
- preprint